查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1803053

2032 年數位安慰劑效應市場預測：按干預類型、技術、交付管道、應用、最終用戶和地區進行的全球分析

Digital Placebo Effect Market Forecasts to 2032 - Global Analysis By Intervention Type, Technology, Delivery Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球數位安慰劑效應市場預計在 2025 年達到 5.475 億美元，到 2032 年將達到 10.3343 億美元，預測期內的複合年成長率為 9.5%。

數位安慰劑效應是指個人在使用數位健康工具、應用程式和設備後體驗到的心理和生理改善，即使這些技術本身並未提供積極的治療性介入。這種效應源自於使用者的期望、感知到的信任以及對科技的參與，從而提升了幸福感並緩解了症狀。與傳統的安慰劑效應類似，它強調了信念、動機和使用者互動在透過數位解決方案推動可衡量的健康結果方面所發揮的作用。

對數位健康解決方案的需求不斷成長

數位健康應用的激增，引發了人們對基於安慰劑的數位干預措施的好奇，這些措施利用用戶的信念來推動實際療效。隨著應用程式、穿戴式裝置和虛擬療法的日益普及，人們逐漸認知到感知療效具有心理效應。人們越來越願意接受非藥物解決方案，尤其是那些提供客製化回饋和參與度的解決方案。數位安慰劑效應是指使用者僅透過信任科技就能獲得真正的益處，而這種效應正在心理健康、慢性疼痛和生活方式管理等領域中研究。這種轉變促使開發人員設計出能夠增強使用者信任和參與度的介面。行為心理學與數位療法的融合正在推動市場成長。

缺乏標準化的定義和規定

在數位安慰劑效應領域，缺乏統一的定義或正式的監管規定限制了其合法性和長期可行性。模糊的界線使企業得以誇大其健康益處，引發倫理爭議並造成混亂。缺乏一致的語言規範阻礙了相關人員之間的合作與協調。監管的不確定性阻礙了資金籌措並扼殺了創新。缺乏連貫的框架，市場可能會出現碎片化，臨床應用也會受到限制。

融入更廣泛的醫療保健生態系統

將數位安慰劑技術融入現有醫療平台，可提升病患參與度與治療效果。透過將安慰劑增強功能融入遠端醫療、行動醫療應用程式和穿戴式設備，醫療服務提供者無需依賴藥物即可增強治療效果。這些工具可以作為傳統療法的補充，提供低風險、經濟高效的治療方案。與健康記錄和遠端監控系統的整合，可以根據個人需求客製化個人化的安慰劑策略。隨著醫療保健逐漸轉向更全面、以患者為中心的模式，數位安慰劑提供了一個引人注目的新維度，為行為和預防保健領域的創新創造了肥沃的土壤。

來自傳統藥物的威脅

成熟的藥物療法對數位安慰劑構成挑戰，尤其是在臨床效果已被驗證的領域。患者和臨床醫生都可能不願意接受這種基於信仰而非生物化學原理的干涉措施。缺乏活性成分可能會引發懷疑，尤其是在嚴重或急性疾病。製藥公司可能認為數位安慰劑具有顛覆性，並抵制其應用。此外，保險政策通常更傾向於傳統治療方法，這使得數位安慰劑工具難以獲得資金支持。這些動態可能會阻礙其被接受，並減緩市場擴張。

COVID-19的影響：

疫情加速了遠端醫療的轉變，並間接增加了人們對數位安慰劑解決方案的興趣。由於無法獲得面對面的醫療服務，使用者轉向了能夠提供安慰和治療價值的虛擬平台。這一趨勢凸顯了信念和期望在健康結果中發揮重要作用，尤其是在心理和情緒健康方面。開發人員為此添加了引導式視覺化、激勵提示和身臨其境型設計等功能，以增強安慰劑效應。然而，這場危機也暴露了這些工具在監管和科學嚴謹性方面存在的不足。

習慣和輔導應用程式細分市場預計將在預測期內成為最大的細分市場

在人工智慧主導製化、行為設計和遊戲化策略的推動下，習慣和輔導類應用預計將在預測期內佔據最大的市場佔有率。值得關注的趨勢包括：結合自學工具和即時輔導的混合模式、行動優先的介面以及可擴展的雲端基礎設施。關鍵的進步包括機器學習技術，能夠實現即時回饋，以及對心理健康和生產力的日益關注。疫情導致遠距個人發展需求激增，促使各組織採用數位化輔導來提升領導力、提高員工敬業度和績效。

預計預測期內 CRO 和製藥領域將出現最高複合年成長率

預計在預測期內，CRO 和製藥業將實現最高成長率，這得益於人工智慧驅動的研究設計、分散式研究模型和客製化研究。目前的趨勢著重於以患者為先的方法、真實世界證據的整合以及靈活的混合試驗。關鍵創新包括基於機器學習的預測分析、透過雲端平台進行遠端監控以及用於結果追蹤的數位生物標記。隨著藥物開發日益複雜，製藥公司越來越依賴精通技術的 CRO 來簡化流程、降低成本並更靈活地應對不斷變化的監管需求。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大市場佔有率，這得益於人工智慧、物聯網和穿戴式技術的廣泛應用，這些技術將有助於個人化醫療解決方案的實現。核心技術包括雲端基礎平台、數位生物標記物和即時數據分析。關鍵趨勢包括去中心化臨床模式、行動優先的健康應用和以使用者為中心的數位療法。近期發展突顯了監管參與度的不斷提升、製藥公司與合約研究組織 (CRO) 之間的策略聯盟，以及對心理健康、慢性病管理和不同人群行為指導領域可擴展且經濟實惠的創新的大力推動。

複合年成長率最高的地區：

預計北美將在預測期內呈現最高的複合年成長率，這得益於尖端人工智慧、數位表現型分析以及專為臨床和行為應用而設計的遠端監控技術。突出的趨勢包括虛擬輔導解決方案、分散式試驗模式以及使用真實​​世界數據檢驗結果。近期的進展包括雲端基礎的可擴展交付基礎設施、對數位療法的監管響應增強，以及製藥公司與合約研究組織 (CRO) 之間合作的深化。該地區強勁的創新格局和醫療保健體系將繼續推動個人化、技術驅動的干涉措施。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球數位安慰劑效應市場（依干預類型）

  • 移動微干預
    • 習慣和指導應用程式
    • 一款增強專注力和預期能力的應用程式
    • 症狀追蹤和反饋應用程式
  • 對話代理
    • 基於規則的聊天機器人
    • 語音助理
    • 基於AI/LLM的伴侶
  • 身臨其境型與多感官
    • 虛擬實境（VR）
    • 視聽神經調節工具
    • 擴增實境/混合實境（AR/MR）
  • 穿戴式裝置和生物回饋療法
    • 腕帶和戒指設備
    • 神經反饋/HRV工具
    • 觸覺和經皮神經電刺激 (TENS) 等消費性設備
  • 研究的安慰劑對照
    • 虛假應用程式的條件
    • 期望一致性通訊協定
    • 注意力控制介面

6. 全球數位安慰劑效應市場（按技術）

  • 數字模態
    • 行動醫療應用程式
    • 穿戴式裝置和生物感測器
    • 遠端醫療平台
  • 身臨其境型技術堆疊
    • VR/AR硬體
    • 神經調節介面
  • 行為設計
    • 遊戲化
    • 回饋迴路
    • 加固系統
  • AI個人化
    • 自適應演算法
    • 期望模型
    • 基於NLP的客製化

7. 全球數位安慰劑效應市場（按分銷管道）

  • 基於應用程式的干涉措施
  • 基於聊天機器人/簡訊
  • 網路為基礎的平台
  • 身臨其境型介面

第8章全球數位安慰劑效應市場（按應用）

  • 心理健康
  • 慢性疼痛管理
  • 睡眠和壓力干預
  • 提升認知能力
  • 其他用途

9. 全球數位安慰劑效應市場（依最終用戶）

  • 病人和消費者
  • 醫療保健提供者
  • 研究機構
  • 付款人和保險公司
  • CRO和製藥公司
  • 其他最終用戶

第 10 章全球數位安慰劑效應市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Pear Therapeutics
  • BioBeats
  • Happify Health
  • TheraVR
  • Akili Interactive
  • Emteq Labs
  • Big Health
  • Somatix
  • Woebot Health
  • BreatheVR
  • MindMaze
  • Neuroelectrics
  • Kaia Health
  • Cognoa
  • Click Therapeutics
  • Flow Neuroscience
  • BehaVR
  • Limbix
Product Code: SMRC30578

According to Stratistics MRC, the Global Digital Placebo Effect Market is accounted for $547.50 million in 2025 and is expected to reach $1033.43 million by 2032 growing at a CAGR of 9.5% during the forecast period. The Digital Placebo Effect refers to the psychological and physiological improvements individuals experience from using digital health tools, apps, or devices, even when these technologies provide no active therapeutic intervention. This effect arises from user expectations, perceived credibility, and engagement with the technology, leading to enhanced well-being or symptom relief. Similar to traditional placebo effects, it highlights the role of belief, motivation, and user interaction in driving measurable health outcomes through digital solutions.

Market Dynamics:

Driver:

Growing demand for digital health solutions

The surge in digital health adoption is sparking curiosity around placebo-based digital interventions that harness user belief to drive real outcomes. As apps, wearables, and virtual therapies become more common, the psychological impact of perceived effectiveness is gaining recognition. People are increasingly open to non-drug solutions, especially those offering tailored feedback and engagement. Digital placebo effects where users experience real benefits simply by trusting the technology are being explored in areas like mental wellness, chronic pain, and lifestyle management. This shift is motivating developers to design interfaces that reinforce user confidence and involvement. The fusion of behavioral psychology with digital therapeutics is accelerating market growth.

Restraint:

Lack of standardized definitions and regulations

A lack of unified definitions and formal regulations in the Digital Placebo Effect space is restraining its legitimacy and long-term viability. Vague boundaries allow firms to exaggerate health benefits, raising ethical red flags and spreading confusion. The absence of consistent language disrupts collaboration and makes it harder for stakeholders to align. Regulatory uncertainty discourages funding and stifles innovation, while eroding public confidence in digital placebo tools. Without a coherent framework, the market risks fragmentation and limited adoption in clinical settings.

Opportunity:

Integration into broader healthcare ecosystems

Digital placebo technologies could be woven into existing healthcare platforms to enhance patient engagement and outcomes. By incorporating placebo-enhancing features into telemedicine, mobile health apps, and wearable devices, providers can amplify therapeutic effects without relying on medication. These tools can serve as supportive layers alongside conventional treatments, offering low-risk and cost-effective options. Integration with health records and remote monitoring systems allows for personalized placebo strategies tailored to individual needs. As healthcare moves toward more holistic and patient-centric models, digital placebos offer a compelling new dimension. This creates fertile ground for innovation in behavioral health and preventive care.

Threat:

Threat from traditional therapeutics

Established drug-based treatments pose a challenge to the digital placebo, especially in areas with proven clinical outcomes. Both patients and clinicians may be hesitant to embrace interventions that rely on belief rather than biochemical action. The absence of active ingredients can lead to skepticism, particularly for serious or acute conditions. Pharmaceutical companies may view digital placebos as disruptive and resist their adoption. Additionally, insurance policies often favor traditional therapies, making it harder for digital placebo tools to gain financial support. These dynamics could hinder acceptance and slow market expansion.

Covid-19 Impact:

The pandemic accelerated the shift to remote care, indirectly boosting interest in digital placebo solutions. With limited access to in-person services, users turned to virtual platforms that offered reassurance and perceived therapeutic value. This trend highlighted how belief and expectation can play a powerful role in health outcomes, especially in mental and emotional well-being. Developers responded by adding features like guided visualization, motivational cues, and immersive design to enhance placebo effects. However, the crisis also revealed gaps in oversight and scientific rigor for these tools.

The habit & coaching apps segment is expected to be the largest during the forecast period

The habit & coaching apps segment is expected to account for the largest market share during the forecast period, propelled by AI-driven customization, behavioural design, and Gamification strategies. Notable trends include hybrid models combining self-guided tools with live coaching, mobile-first interfaces, and scalable cloud infrastructure. Key advancements involve machine learning for real-time feedback and growing interest in mental health and productivity enhancement. The pandemic catalyzed a surge in remote self-improvement, prompting organizations to adopt digital coaching for leadership development, employee engagement, and performance enhancement.

The CROs & pharma segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the CROs & pharma segment is predicted to witness the highest growth rate, driven by AI-enabled trial design, decentralized research models, and tailored therapeutics. Current trends highlight patient-first approaches, integration of real-world evidence, and flexible hybrid trials. Key innovations include predictive analytics via machine learning, remote monitoring through cloud platforms, and digital biomarkers for tracking outcomes. As drug development grows more complex, pharma increasingly relies on tech-savvy CROs to streamline processes, cut costs, and meet evolving regulatory demands with greater agility.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to widespread adoption of AI, IoT, and wearable technologies that enable personalized health solutions. Core technologies include cloud-based platforms, digital biomarkers, and real-time data analytics. Key trends involve decentralized clinical models, mobile-first wellness applications, and user-centric digital therapeutics. Recent developments highlight growing regulatory engagement, strategic collaborations between pharma and CROs, and a strong push toward scalable, affordable innovations in mental health, chronic disease management, and behavioural coaching across diverse populations.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by cutting-edge AI, digital phenotyping, and remote monitoring technologies designed for clinical and behavioural applications. Prominent trends include virtual coaching solutions, decentralized trial formats, and the use of real-world data to validate outcomes. Recent advancements feature cloud-based infrastructure for scalable delivery, growing regulatory alignment with digital therapeutics, and deeper collaboration between pharmaceutical firms and CROs. The region's strong innovation landscape and healthcare systems continue to drive personalized, tech-enabled interventions.

Key players in the market

Some of the key players in Digital Placebo Effect Market include Pear Therapeutics, BioBeats, Happify Health, TheraVR, Akili Interactive, Emteq Labs, Big Health, Somatix, Woebot Health, BreatheVR, MindMaze, Neuroelectrics, Kaia Health, Cognoa, Click Therapeutics, Flow Neuroscience, BehaVR, and Limbix.

Key Developments:

In July 2022, Big Health has acquired Limbix, creators of the first, evidence-based digital therapeutic for teens and young adults with symptoms of depression. Since its founding in 2016, Limbix has raised $30 million through its Series A funding round and has built a research-based pipeline of adolescent products.

In July 2022, Biobeat announces its newest partner M-ighty in the Belgian Market. Biobeat's expansion in the Belgian market gains momentum with the exciting collaboration with their latest partner, M-ighty. This strategic partnership has been established to enhance the presence of Biobeat's cutting-edge monitoring system in Belgium's healthcare landscape. The announcement marks a significant step forward in Biobeat's mission to provide innovative solutions for clinical patient care and remote patient monitoring.

In May 2020, SOMATEX introduces the Lung Marker System in the US. Recently FDA listed, the tried and tested lung tissue marker enables secure localization of smaller, non-superficial pulmonary nodules. "We are excited to launch our product in the US to fulfill the growing market need for lung tumor localization," says Dan Furnas, Vice President Sales at SOMATEX USA.

Intervention Types Covered:

  • Mobile Micro-interventions
  • Conversational Agents
  • Immersive & Multisensory
  • Wearables & Biofeedback
  • Placebo Controls for Trials

Technologies Covered:

  • Digital Modalities
  • Immersive Tech Stack
  • Behavioral Design
  • AI Personalization

Delivery Channels Covered:

  • App-based interventions
  • Chatbot/SMS-based
  • Web-based platforms
  • Immersive Interfaces

Applications Covered:

  • Mental health
  • Chronic pain management
  • Sleep and stress interventions
  • Cognitive enhancement
  • Other Applications

End Users Covered:

  • Patients & Consumers
  • Healthcare providers
  • Research institutions
  • Payers and insurers
  • CROs & Pharma
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Digital Placebo Effect Market, By Intervention Type

  • 5.1 Introduction
  • 5.2 Mobile Micro-interventions
    • 5.2.1 Habit & Coaching Apps
    • 5.2.2 Mindfulness & Expectation-Priming Apps
    • 5.2.3 Symptom Tracking & Feedback Apps
  • 5.3 Conversational Agents
    • 5.3.1 Rule-based Chatbots
    • 5.3.2 Voice Assistants
    • 5.3.3 AI/LLM-based Companions
  • 5.4 Immersive & Multisensory
    • 5.4.1 Virtual Reality (VR)
    • 5.4.2 Audio-visual Neuromodulation Tools
    • 5.4.3 Augmented/Mixed Reality (AR/MR)
  • 5.5 Wearables & Biofeedback
    • 5.5.1 Wrist & Ring Devices
    • 5.5.2 Neurofeedback/HRV Tools
    • 5.5.3 Haptics & TENS-like Consumer Devices
  • 5.6 Placebo Controls for Trials
    • 5.6.1 Sham App Conditions
    • 5.6.2 Expectancy-Matched Protocols
    • 5.6.3 Attentional Control Interfaces

6 Global Digital Placebo Effect Market, By Technology

  • 6.1 Introduction
  • 6.2 Digital Modalities
    • 6.2.1 Mobile health apps
    • 6.2.2 Wearable devices and biosensors
    • 6.2.3 Telemedicine platforms
  • 6.3 Immersive Tech Stack
    • 6.3.1 VR/AR hardware
    • 6.3.2 Neuromodulation interfaces
  • 6.4 Behavioral Design
    • 6.4.1 Gamification
    • 6.4.2 Feedback loops
    • 6.4.3 Reinforcement systems
  • 6.5 AI Personalization
    • 6.5.1 Adaptive algorithms
    • 6.5.2 Expectancy modeling
    • 6.5.3 NLP-based tailoring

7 Global Digital Placebo Effect Market, By Delivery Channel

  • 7.1 Introduction
  • 7.2 App-based interventions
  • 7.3 Chatbot/SMS-based
  • 7.4 Web-based platforms
  • 7.5 Immersive Interfaces

8 Global Digital Placebo Effect Market, By Application

  • 8.1 Introduction
  • 8.2 Mental health
  • 8.3 Chronic pain management
  • 8.4 Sleep and stress interventions
  • 8.5 Cognitive enhancement
  • 8.6 Other Applications

9 Global Digital Placebo Effect Market, By End User

  • 9.1 Introduction
  • 9.2 Patients & Consumers
  • 9.3 Healthcare providers
  • 9.4 Research institutions
  • 9.5 Payers and insurers
  • 9.6 CROs & Pharma
  • 9.7 Other End Users

10 Global Digital Placebo Effect Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Pear Therapeutics
  • 12.2 BioBeats
  • 12.3 Happify Health
  • 12.4 TheraVR
  • 12.5 Akili Interactive
  • 12.6 Emteq Labs
  • 12.7 Big Health
  • 12.8 Somatix
  • 12.9 Woebot Health
  • 12.10 BreatheVR
  • 12.11 MindMaze
  • 12.12 Neuroelectrics
  • 12.13 Kaia Health
  • 12.14 Cognoa
  • 12.15 Click Therapeutics
  • 12.16 Flow Neuroscience
  • 12.17 BehaVR
  • 12.18 Limbix

List of Tables

  • Table 1 Global Digital Placebo Effect Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Digital Placebo Effect Market Outlook, By Intervention Type (2024-2032) ($MN)
  • Table 3 Global Digital Placebo Effect Market Outlook, By Mobile Micro-interventions (2024-2032) ($MN)
  • Table 4 Global Digital Placebo Effect Market Outlook, By Habit & Coaching Apps (2024-2032) ($MN)
  • Table 5 Global Digital Placebo Effect Market Outlook, By Mindfulness & Expectation-Priming Apps (2024-2032) ($MN)
  • Table 6 Global Digital Placebo Effect Market Outlook, By Symptom Tracking & Feedback Apps (2024-2032) ($MN)
  • Table 7 Global Digital Placebo Effect Market Outlook, By Conversational Agents (2024-2032) ($MN)
  • Table 8 Global Digital Placebo Effect Market Outlook, By Rule-based Chatbots (2024-2032) ($MN)
  • Table 9 Global Digital Placebo Effect Market Outlook, By Voice Assistants (2024-2032) ($MN)
  • Table 10 Global Digital Placebo Effect Market Outlook, By AI/LLM-based Companions (2024-2032) ($MN)
  • Table 11 Global Digital Placebo Effect Market Outlook, By Immersive & Multisensory (2024-2032) ($MN)
  • Table 12 Global Digital Placebo Effect Market Outlook, By Virtual Reality (VR) (2024-2032) ($MN)
  • Table 13 Global Digital Placebo Effect Market Outlook, By Audio-visual Neuromodulation Tools (2024-2032) ($MN)
  • Table 14 Global Digital Placebo Effect Market Outlook, By Augmented/Mixed Reality (AR/MR) (2024-2032) ($MN)
  • Table 15 Global Digital Placebo Effect Market Outlook, By Wearables & Biofeedback (2024-2032) ($MN)
  • Table 16 Global Digital Placebo Effect Market Outlook, By Wrist & Ring Devices (2024-2032) ($MN)
  • Table 17 Global Digital Placebo Effect Market Outlook, By Neurofeedback/HRV Tools (2024-2032) ($MN)
  • Table 18 Global Digital Placebo Effect Market Outlook, By Haptics & TENS-like Consumer Devices (2024-2032) ($MN)
  • Table 19 Global Digital Placebo Effect Market Outlook, By Placebo Controls for Trials (2024-2032) ($MN)
  • Table 20 Global Digital Placebo Effect Market Outlook, By Sham App Conditions (2024-2032) ($MN)
  • Table 21 Global Digital Placebo Effect Market Outlook, By Expectancy-Matched Protocols (2024-2032) ($MN)
  • Table 22 Global Digital Placebo Effect Market Outlook, By Attentional Control Interfaces (2024-2032) ($MN)
  • Table 23 Global Digital Placebo Effect Market Outlook, By Technology (2024-2032) ($MN)
  • Table 24 Global Digital Placebo Effect Market Outlook, By Digital Modalities (2024-2032) ($MN)
  • Table 25 Global Digital Placebo Effect Market Outlook, By Mobile health apps (2024-2032) ($MN)
  • Table 26 Global Digital Placebo Effect Market Outlook, By Wearable devices and biosensors (2024-2032) ($MN)
  • Table 27 Global Digital Placebo Effect Market Outlook, By Telemedicine platforms (2024-2032) ($MN)
  • Table 28 Global Digital Placebo Effect Market Outlook, By Immersive Tech Stack (2024-2032) ($MN)
  • Table 29 Global Digital Placebo Effect Market Outlook, By VR/AR hardware (2024-2032) ($MN)
  • Table 30 Global Digital Placebo Effect Market Outlook, By Neuromodulation interfaces (2024-2032) ($MN)
  • Table 31 Global Digital Placebo Effect Market Outlook, By Behavioral Design (2024-2032) ($MN)
  • Table 32 Global Digital Placebo Effect Market Outlook, By Gamification (2024-2032) ($MN)
  • Table 33 Global Digital Placebo Effect Market Outlook, By Feedback loops (2024-2032) ($MN)
  • Table 34 Global Digital Placebo Effect Market Outlook, By Reinforcement systems (2024-2032) ($MN)
  • Table 35 Global Digital Placebo Effect Market Outlook, By AI Personalization (2024-2032) ($MN)
  • Table 36 Global Digital Placebo Effect Market Outlook, By Adaptive algorithms (2024-2032) ($MN)
  • Table 37 Global Digital Placebo Effect Market Outlook, By Expectancy modeling (2024-2032) ($MN)
  • Table 38 Global Digital Placebo Effect Market Outlook, By NLP-based tailoring (2024-2032) ($MN)
  • Table 39 Global Digital Placebo Effect Market Outlook, By Delivery Channel (2024-2032) ($MN)
  • Table 40 Global Digital Placebo Effect Market Outlook, By App-based interventions (2024-2032) ($MN)
  • Table 41 Global Digital Placebo Effect Market Outlook, By Chatbot/SMS-based (2024-2032) ($MN)
  • Table 42 Global Digital Placebo Effect Market Outlook, By Web-based platforms (2024-2032) ($MN)
  • Table 43 Global Digital Placebo Effect Market Outlook, By Immersive Interfaces (2024-2032) ($MN)
  • Table 44 Global Digital Placebo Effect Market Outlook, By Application (2024-2032) ($MN)
  • Table 45 Global Digital Placebo Effect Market Outlook, By Mental health (2024-2032) ($MN)
  • Table 46 Global Digital Placebo Effect Market Outlook, By Chronic pain management (2024-2032) ($MN)
  • Table 47 Global Digital Placebo Effect Market Outlook, By Sleep and stress interventions (2024-2032) ($MN)
  • Table 48 Global Digital Placebo Effect Market Outlook, By Cognitive enhancement (2024-2032) ($MN)
  • Table 49 Global Digital Placebo Effect Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 50 Global Digital Placebo Effect Market Outlook, By End User (2024-2032) ($MN)
  • Table 51 Global Digital Placebo Effect Market Outlook, By Patients & Consumers (2024-2032) ($MN)
  • Table 52 Global Digital Placebo Effect Market Outlook, By Healthcare providers (2024-2032) ($MN)
  • Table 53 Global Digital Placebo Effect Market Outlook, By Research institutions (2024-2032) ($MN)
  • Table 54 Global Digital Placebo Effect Market Outlook, By Payers and insurers (2024-2032) ($MN)
  • Table 55 Global Digital Placebo Effect Market Outlook, By CROs & Pharma (2024-2032) ($MN)
  • Table 56 Global Digital Placebo Effect Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.